Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Belite Bio, Inc. Sponsored ADR (BLTE) had Weighted-Average Shares Outstanding (Diluted) of 33.22M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-21.69M |
|
-- |
|
-- |
|
$23.02M |
|
$-23.02M |
|
$1.33M |
|
$-21.69M |
|
$-21.69M |
|
$-21.69M |
|
$-21.69M |
|
$-21.69M |
|
$-21.69M |
|
$-23.02M |
|
$-23.02M |
|
33.22M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
33.22M |
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$277.21M |
|
$0.32M |
|
$5.18M |
|
$282.39M |
|
$8.07M |
|
-- |
|
$0.24M |
|
$8.31M |
|
$274.08M |
|
$274.06M |
|
$274.08M |
|
34.89M |
|
| Cash Flow Statement Financials | |
$-26.60M |
|
$-1.37M |
|
$153.12M |
|
$31.68M |
|
$157.03M |
|
$125.36M |
|
$27.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.91% |
|
-7.68% |
|
-7.91% |
|
$7.86 |
|
-- |
|
-- |
|